Elaine Caughey - Jun 21, 2021 Form 3 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Chief Business Officer
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
3
Date filed
6/21/2021, 05:32 PM
Next filing
Mar 3, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney